Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs

Allenmark, 2003, Induced circular dichroism by chiral molecular interaction, Chirality, 15, 409, 10.1002/chir.10220 Anand, 2012, b-Cyclodextrin polymer nanoparticles as carriers for doxorubicin and artemisinin: a spectroscopic and photophysical study, Photochem. Photobiol. Sci., 11, 1285, 10.1039/c2pp25014d Anand, 2012, A close-up on doxorubicin binding to gamma-cyclodextrin: an elucidating spectroscopic, photophysical and conformational study, RSC Adv., 2, 2346, 10.1039/c2ra01221a Baulard, 2000, Activation of the pro-drug ethionamide is regulated in mycobaeteria, J. Biol. Chem., 275, 28326 Blondiaux, 2017, Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420, Science, 355, 1206, 10.1126/science.aag1006 Case, D.A., Betz, R.M., Botello-Smith, W., Cerutti, D.S., Cheatham, T.E., Darden, I.T.A., Duke, R.E., Giese, T.J., Gohlke, H., Goetz, A.W., Homeyer, N., Izadi, S., Janowski, P., Kaus, J., Kovalenko, A., Lee, T.S., LeGrand, S., Li, P., Lin, C., Luchko, T., Luo, R., Madej, B., Mermelstein, D., Merz, K.M., Monard, G., Nguyen, H., Nguyen, H.T., Omelyan, I., Onufriev, A., Roe, D.R., Roitberg, A., Sagui, C., Simmerling, C.L., Swails, J., Walker, R.C., Wang, J., Wolf, R.M., Wu, X., Xiao, L., York, D.M., Kollman, P.A., 2016. AMBER 2016. University of California, San Francisco. ChemAxon, 2016 Daoud-Mahammed, 2007, Novel self-assembling nanogels: stability and lyophilisation studies, Int. J. Pharm., 332, 185, 10.1016/j.ijpharm.2006.09.052 Daoud-Mahammed, 2007, Spontaneous association of hydrophobized dextran and poly-beta-cyclodextrin into nanoassemblies. Formation and interaction with a hydrophobic drug, ‎J. Colloid Interface Sci., 307, 83, 10.1016/j.jcis.2006.10.072 Daoud-Mahammed, 2008, Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs, J. Biomed. Mater. Res. A, 86A, 736, 10.1002/jbm.a.31674 Daoud-Mahammed, 2009, Cyclodextrin and polysaccharide-Based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen, Biomacromolecules, 10, 547, 10.1021/bm801206f Duchêne, 2016, Small is beautiful: surprising nanoparticles, Int. J. Pharm., 502, 219, 10.1016/j.ijpharm.2016.02.016 Duchêne, 2003, Cyclodextrins and emulsions, Int. J. Pharm., 266, 85, 10.1016/S0378-5173(03)00384-3 Duchêne, 2016, Cyclodextrin-based polymeric nanoparticles as efficient carriers for anticancer drugs, Curr. Pharm. Biotechnol., 17, 248, 10.2174/1389201017666151030104944 Dupradeau, 2010, The R.E.D. tools: advances in RESP and ESP charge derivation and force field library building, Phys. Chem. Chem. Phys., 12, 7821, 10.1039/c0cp00111b Fraix, 2013, An engineered nanoplatform for bimodal anticancer phototherapy with dual-color fluorescence detection of sensitizers, Chem. Commun., 49, 4459, 10.1039/c3cc40714d Frisch, 2016 Gref, 2012, Cyclodextrins as smart components of polymer nanoparticles, J. Drug Deliv. Sci. Technol., 22, 223, 10.1016/S1773-2247(12)50033-X Gref, 2006, New self-assembled nanogels based on host-guest interactions: characterization and drug loading, J. Control. Rel., 111, 316, 10.1016/j.jconrel.2005.12.025 Hamdi, 2001, Formulation of epichlorohydrin cross-linked starch microspheres, J. Microencapsul., 18, 373, 10.1080/02652040010019505 Henderson, 2008, Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1: FMO2 and FMO3 and mouse and human lung microsomes, Toxicol. Appl. Pharmacol., 233, 420, 10.1016/j.taap.2008.09.017 Humphrey, 1996, VMD: visual molecular dynamics, J. Mol. Graph., 14, 33, 10.1016/0263-7855(96)00018-5 Kirschner, 2008, GLYCAM06: a generalizable biomolecular force field: carbohydrates, J. Comput. Chem., 29, 622, 10.1002/jcc.20820 Loftsson, 1996, Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization, J. Pharm. Sci., 85, 1017, 10.1021/js950534b Mazzaferro, 2013, Oral delivery of anticancer drugs III: formulation using drug delivery systems, Drug Discov. Today, 18, 99, 10.1016/j.drudis.2012.08.007 Monti, 2016, Photoresponsive cyclodextrin nanosystems: design, structure and function, vol. 43, 226 Othman, 2011, A comprehensive study of the spontaneous formation of nanoassemblies in water by a lock-and-key interaction between two associative polymers, ‎J. Colloid Interface Sci., 354, 517, 10.1016/j.jcis.2010.11.015 Pandey, 2005, Antitubercular inhaled therapy: opportunities, progress and challenges, J. Antimicrob. Chemother., 55, 430, 10.1093/jac/dki027 Phillips, 2005, Scalable molecular dynamics with NAMD, J. Comput. Chem., 26, 1781, 10.1002/jcc.20289 Raffaini, 2007, Molecular dynamics study of hostâ€guest interactions in cyclodextrins: methodology and data analysis for a comparison with solution data and the solid-state structure, J. Inclusion Phenom. Macrocyclic Chem., 57, 683, 10.1007/s10847-006-9265-0 Ramos, 2010, Experimental crystal structure determination of b-cyclodextrin, CCDC Villemagne, 2014, Ligand efficiency driven design of new inhibitors of mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches, J. Med. Chem., 57, 4876, 10.1021/jm500422b Wang, 2004, Development and testing of a general amber force field, J. Comput. Chem., 25, 1157, 10.1002/jcc.20035 Wankar, 2017, Efficient loading of ethionamide in cyclodextrin-based carriers offers enhanced solubility and inhibition of drug crystallization, Int. J. Pharm., 531, 568, 10.1016/j.ijpharm.2017.05.041 Willand, 2009, Synthetic EthR inhibitors boost antituberculous activity of ethionamide, Nat. Med., 15, 537, 10.1038/nm.1950 Zaman, 2014, 415 Zsila, 2010